Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans
- PMID: 15589487
- DOI: 10.1016/j.amjmed.2004.05.028
Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans
Abstract
Purpose: To determine whether use of regular aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) is a risk factor for a false-positive fecal occult blood test result.
Methods: Consecutive patients referred for colonoscopy for a positive fecal occult blood test result at a Veterans Affairs hospital were eligible. Patients with hematochezia, peptic ulcer disease, or unevaluated dyspepsia requiring antacids, or who used warfarin, were excluded. Regular aspirin and NSAID use was defined as at least one daily dose for at least 3 days per week. Colonoscopic findings unlikely to explain a positive test result alone were defined a priori as diverticulosis, hemorrhoids, or polyps <1.0 cm with no villous histology. Findings likely to explain a positive test result included cancer and advanced polyps.
Results: The sample comprised 193 veterans with a mean (+/- SD) age of 66 +/- 10 years; 98% were male and 86% were white. No colonoscopic findings explained the positive fecal occult blood test result in 153 patients (79%). One hundred and thirty-five patients (70%) were regular aspirin or NSAID users, of whom 21% (n = 29) had findings to explain the positive test results, compared with 19% (11/58) of nonusers (P = 0.7). There was no relation between aspirin dose and colonoscopic findings unlikely to explain a positive test result. Multivariate analysis found no association between regular aspirin or NSAID use and a false-positive test result (odds ratio = 0.85; 95% confidence interval: 0.39 to 1.84).
Conclusion: Aspirin and NSAID use were not risk factors for a false-positive fecal occult blood test result in this study.
Similar articles
-
Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.N Engl J Med. 1998 Jul 16;339(3):153-9. doi: 10.1056/NEJM199807163390303. N Engl J Med. 1998. PMID: 9664091
-
A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.J Natl Cancer Inst. 2005 Jul 6;97(13):975-80. doi: 10.1093/jnci/dji173. J Natl Cancer Inst. 2005. PMID: 15998950
-
Bleeding risk after invasive procedures in aspirin/NSAID users: polypectomy study in veterans.Am J Med. 2012 Dec;125(12):1222-7. doi: 10.1016/j.amjmed.2012.05.030. Am J Med. 2012. PMID: 23164486
-
Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.Am J Gastroenterol. 2009 Apr;104(4):933-8. doi: 10.1038/ajg.2009.14. Epub 2009 Mar 17. Am J Gastroenterol. 2009. PMID: 19293792
-
[Demonstration and quantification of occult fecal blood loss. Critical evaluation of chemical and nuclear medicine technics].Med Klin. 1978 Aug 25;73(34):1163-9. Med Klin. 1978. PMID: 355818 Review. German. No abstract available.
Cited by
-
Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy in a Colorectal Cancer Screening Program.Med Princ Pract. 2019;28(2):193-195. doi: 10.1159/000494839. Epub 2018 Oct 25. Med Princ Pract. 2019. PMID: 30359984 Free PMC article.
-
Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms.BMC Cancer. 2018 Sep 24;18(1):914. doi: 10.1186/s12885-018-4826-3. BMC Cancer. 2018. PMID: 30249195 Free PMC article. Clinical Trial.
-
Sensitivity of fecal occult blood testing in the cat.J Feline Med Surg. 2017 Jun;19(6):603-608. doi: 10.1177/1098612X16643752. Epub 2016 Apr 15. J Feline Med Surg. 2017. PMID: 27084754 Free PMC article.
-
Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532. Sci Rep. 2016. PMID: 26787510 Free PMC article.
-
Use of CT colonography in the English Bowel Cancer Screening Programme.Gut. 2014 Jun;63(6):964-73. doi: 10.1136/gutjnl-2013-304697. Epub 2013 Aug 16. Gut. 2014. PMID: 23955527 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
